Description
Admatrone (Abiraterone acetate) is an anticancer drug, available in tablet form for oral administration.
Generic Name– Abiraterone acetate
Drug Class– Antineoplastic agentAbiraterone acetate is a new cytochrome P450 (CYP) 17 inhibitor approved by the FDA for use in combination with prednisone for castration resistant prostate cancer. It selectively inhibits androgen biosynthesis by blocking cytochrome P450 c17 (CYP17), a critical enzyme in testosterone synthesis and highly expressed in adrenal glands, testes and within the prostate tumor.
Admatrone (Abiraterone acetate) is an anticancer drug, available in tablet form for oral administration.
Adverse Reactions
Contraindications